Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares U.S. Healthcare ETF (IYH) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. IYH is less expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.6% for FTXH. IYH is down -1.84% year-to-date (YTD) with -$496M in YTD flows. FTXH performs better with 5.06% YTD performance, and +$7M in YTD flows. Run a side-by-side ETF comparison of IYH and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IYH FTXH | -2.08%-0.60% | -0.90%+7.47% | -1.84%+5.06% | +6.00%+22.29% | +25.78%+43.33% | +36.39%+43.47% |
| Flows | IYH FTXH | -$245M+$5M | -$580M+$9M | -$496M+$7M | -$318M+$10M | -$643M-$13M | -$164M+$4M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IYH FTXH | +13.70%+15.29% | +17.71%+20.64% | +13.80%+15.87% | +14.71%+15.67% |
| Max drawdown | IYH FTXH | -5.23%-4.33% | -12.43%-17.49% | -17.89%-19.32% | -17.89%-19.32% |
| Max drawdown duration | IYH FTXH | 63d9d | 211d203d | 445d393d | 445d393d |
IYH | FTXH | |
Last sale 3/11/2026 at 1:30 PM | $63.88 | $34.46 |
| Previous close 03/11/2026 | $64.05 | $34.57 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IYH | FTXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IYH | FTXH | |
|---|---|---|
| Last price | $63.88 | $34.46 |
| 1D performance | -0.27% | -0.33% |
| AuM | $3.02 B | $29.41 M |
| E/R | 0.38% | 0.6% |
IYH | FTXH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | iShares | First Trust |
| Benchmark | Russell 1000 Health Care RIC 22.5/45 Capped Gross Index | NASDAQ US Smart Pharmaceuticals Index |
| N° of holdings | 96 | 49 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 12, 2000 | September 20, 2016 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
